raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:100070

Progressive non-fluent aphasia

Synonyms: Agramatic variant of PPA · Agramatic variant of primary progressive aphasia · Non-fluent variant PPA

Type
Disease
Group
Disorder
Inheritance
Multigenic/multifactorial, Not applicable
Age of onset
Adult
Status
active

Progressive non-fluent aphasia (PNFA) is a form of frontotemporal dementia (FTD), characterized by agrammatism, laborious speech, alexia, and agraphia, frequently accompanied by apraxia of speech (AOS). Language comprehension is relatively preserved.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enProgressive non-fluent aphasiaAgramatic variant of PPA · Agramatic variant of primary progressive aphasia · Non-fluent variant PPA
frAphasie primaire progressive non fluenteAPP agrammatique · APP non fluente · Aphasie primaire progressive agrammatique
deAphasie, nicht-flüssige progredienteAgrammatische Variante der PPA · Agrammatische Variante der primären progredienten Aphasie
esAfasia progresiva no fluenteAPP variante no fluente · PPA variante no fluida · Variante agramatical de APP · Variante agramátical de la afasia progresiva primaria
itAfasia progressiva non fluentePPA, variante agrammatica · PPA, variante non fluente · Variante agrammatica dell'afasia progressiva primitiva
nlProgressieve niet-vloeiende afasieAgrammatische variant van PPA · Agrammatische variant van primaire progressieve afasie · Niet-vloeiende variant van PPA
ptAfasia, progressiva primária, tipo não-fluente
plPostępująca niepłynna afazjaAgramatyczny wariant pierwotnej postępującej afazji · Agramatyczny wariant PPA · Niepłynny wariant PPA
csProgresivní nonfluentní afázieAgramatická varianta PPA · Agramatická varianta primární progresivní afázie · Nonfluentní varianta PPA
ukПрогресуюча невиражена афазіяАграматичний варіант PPA · Аграматичний варіант первинної прогресуючої афазії · Непроточний варіант PPA
zh进行性非流利性失语非语法型原发性进行性失语
trİlerleyici akıcı olmayan afaziAkıcı olmayan değişken PPA · PPA'nın agramatik varyantı · Primer ilerleyici afazinin agramatik varyantı

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM172700NTBTvalidated
OMIM600274NTBTvalidated
OMIM607485NTBTvalidated
ICD-10G31.0NTBTattributedvalidated
ICD-116D83NTBTindexvalidated
MONDO0015059Evalidated
MeSHD057178Evalidated
UMLSC0751706Evalidated
GARD10793Evalidated
MedDRA10029542Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (3):

No children.

4

Genes

8 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
PSEN1Disease-causing germline mutation(s) inAssessedHGNC:9508ENSG0000008081510431114q24.2presenilin 115122701[PMID]
C9ORF72Major susceptibility factor inNot yet assessedHGNC:28337ENSG000001478946142609p21.2C9orf72-SMCR8 complex subunit23597030[PMID]
CHMP2BMajor susceptibility factor inAssessedHGNC:24537ENSG000000839376095123p11.2charged multivesicular body protein 2B23597030[PMID]
GRNMajor susceptibility factor inAssessedHGNC:4601ENSG0000003058213894517q21.31granulin precursor23597030[PMID]
MAPTMajor susceptibility factor inAssessedHGNC:6893ENSG0000018686815714017q21.31microtubule associated protein tau23597030[PMID]
TMEM106BMajor susceptibility factor inAssessedHGNC:22407ENSG000001064606134137p21.3transmembrane protein 106B27543298[PMID]_21614538[PMID]
TREM2Major susceptibility factor inAssessedHGNC:17761ENSG000000959706050866p21.1triggering receptor expressed on myeloid cells 225042114[PMID]
VCPMajor susceptibility factor inNot yet assessedHGNC:12666ENSG000001652806010239p13.3valosin containing protein23597030[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Point prevalence1-9 / 100 0002.5 / 100 000EuropeValue and classValidated22608668[PMID]_European Medicines Agency 2010[OTHER]
Annual incidence1-9 / 1 000 0000.7 / 100 000EuropeValue and classNot yet validated22608668[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

32 annotations · validated 2016-05-02
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0002381Aphasia
HP:0006892Frontotemporal cerebral atrophy
HP:0002145Frontotemporal dementia
HP:0006977Grammar-specific speech disorder
HP:0002354Memory impairment
HP:0001268Mental deterioration
HP:0030391Spoken Word Recognition Deficit
HP:0007112Temporal cortical atrophy
HP:0000474Thickened nuchal skin fold
Frequent (79-30%)
HP:0012658Abnormal brain FDG positron emission tomography
HP:0002500Abnormal cerebral white matter morphology
HP:0010523Alexia
HP:0000739Anxiety
HP:0002186Apraxia
HP:0000716Depression
HP:0011204EEG with continuous slow activity
Occasional (29-5%)
HP:0002366Abnormal lower motor neuron morphology
HP:0002071Abnormality of extrapyramidal motor function
HP:0002446Astrocytosis
HP:0000708Atypical behavior
HP:0010526Dysgraphia
HP:0002427Motor aphasia
HP:0002300Mutism
HP:0001300Parkinsonism
HP:0030223Perseveration
HP:0000751Personality changes
HP:0000711Restlessness
HP:0100256Senile plaques
Excluded (0%)
HP:0030692Brain neoplasm
HP:0100315Lewy bodies
HP:0002185Neurofibrillary tangles
HP:0001297Stroke

Run the differential on the 9 obligate / very frequent terms

Annotation source: 11310619[PMID]_7114808[PMID]_22608668[PMID]

7

Sources for this card